We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Blacktrace Holdings Ltd. to in-license PerkinElmer Technology
News

Blacktrace Holdings Ltd. to in-license PerkinElmer Technology

Blacktrace Holdings Ltd. to in-license PerkinElmer Technology
News

Blacktrace Holdings Ltd. to in-license PerkinElmer Technology

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Blacktrace Holdings Ltd. to in-license PerkinElmer Technology"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Blacktrace Holdings Limited today announced that it has entered into an agreement with PerkinElmer to license certain microfluidic technology owned by its subsidiary, Caliper Life Sciences, Inc., for a wide range of applications. The Blacktrace group includes a number of well-known brands. Dolomite Microfluidics is a leading solution provider of systems and components such as microfluidic droplet systems, microfluidic chips, pumps and connectors, as well as custom solutions and bespoke product development services. Syrris is a leader in chemistry tools, with its award-winning 4th generation Asia Flow Chemistry System being the most successful flow reactor ever.

The license provides Blacktrace with maximum flexibility as it expands its product ranges to include more microfluidic chips and technology, and develops new innovative platforms that will deliver superior performance to its customers worldwide. PerkinElmer continues to leverage its microfluidics portfolio through licensing collaborations to extend its market reach.

Advertisement